Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
      Description

      This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells.

      Conditions
      Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 InfectionNK-Cell Lymphoma, UnclassifiablePrimary Systemic Anaplastic Large Cell Lymphoma, ALK-NegativeRecurrent Adult T-Cell Leukemia/LymphomaRecurrent Anaplastic Large Cell LymphomaRecurrent Angioimmunoblastic T-cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Mycosis FungoidesRefractory Adult T-Cell Leukemia/LymphomaRefractory Anaplastic Large Cell LymphomaRefractory Angioimmunoblastic T-cell LymphomaRefractory Enteropathy-Associated T-Cell LymphomaRefractory Mycosis FungoidesRefractory Nasal Type Extranodal NK/T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
      Talk to us
      RECRUITING
      A Registry for People With T-cell Lymphoma
      Description

      The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

      Conditions
      T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic LeukemiaT-cell Large Granular Lymphocytic LeukemiaChronic Lymphoproliferative Disorder of NK CellsAggressive NK-cell LeukemiaSystemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of ChildhoodChronic Active EBV Infection of T-and NK-Cell Type, Systemic FormHydroa Vacciniforme-Like Lymphoproliferative DisorderAdult T-cell Leukemia/LymphomaExtranodal NK/T-cell Lymphoma, Nasal TypeEnteropathy-associated T-cell LymphomaMonomorphic Epitheliotropic Intestinal T-Cell LymphomaIntestinal T-Cell Lymphoma, Not Otherwise SpecifiedIndolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal TractHepatosplenic T-cell LymphomaSubcutaneous Panniculitis-Like T-Cell LymphomaMycosis FungoidesSezary SyndromePrimary Cutaneous Anaplastic Large Cell LymphomaPrimary Cutaneous T-cell LymphomaPrimary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell LymphomaPrimary Cutaneous Acral CD8-Positive T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeAnaplastic Large Cell Lymphoma, ALK-PositiveAnaplastic Large Cell Lymphoma, ALK-negativeBreast Implant-Associated Anaplastic Large Cell Lymphoma
      Talk to us